Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Small Interfering Rnas (Sirnas) in Cancer Therapy: A Nano-Based Approach Publisher Pubmed



Mahmoodi Chalbatani G1 ; Dana H1, 2 ; Gharagouzloo E1 ; Grijalvo S3, 4 ; Eritja R3, 4 ; Logsdon CD5, 6 ; Memari F1 ; Miri SR1 ; Rad MR7 ; Marmari V2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Science, Tehran, Iran
  2. 2. Department of Biology, Islamic Azad University, Damghan Branch, Damghan, Iran
  3. 3. Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, 08034, Spain
  4. 4. Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER BBN), Madrid, Spain
  5. 5. Department of Cancer Biology, University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States
  6. 6. Department of GI Medical Oncology, University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States
  7. 7. Department of Biology, Zabol University, Zabol, Iran

Source: International journal of nanomedicine Published:2019


Abstract

Cancer is one of the most complex diseases that has resulted in multiple genetic disorders and cellular abnormalities. Globally, cancer is the most common health concern disease that is affecting human beings. Great efforts have been made over the past decades in biology with the aim of searching novel and more efficient tools in therapy. Thus, small interfering RNAs (siRNAs) have been considered one of the most noteworthy developments which are able to regulate gene expression following a process known as RNA interference (RNAi). RNAi is a post-transcriptional mechanism that involves the inhibition of gene expression through promoting cleavage on a specific area of a target messenger RNA (mRNA). This technology has shown promising therapeutic results for a good number of diseases, especially in cancer. However, siRNA therapeutics have to face important drawbacks in therapy including stability and successful siRNA delivery in vivo. In this regard, the development of effective siRNA delivery systems has helped addressing these issues by opening novel therapeutic windows which have allowed to build up important advances in Nanomedicine. In this review, we discuss the progress of siRNA therapy as well as its medical application via nanoparticle-mediated delivery for cancer treatment.